Mackay Memorial Hospital, established on 26 December 1912, is one of the largest medical centers in Taiwan. It is a private Christian hospital in Zhongshan District, Taipei, Taiwan, mostly associated with George Leslie Mackay, the first modern missionary to northern Taiwan.

There are 1,200 (Taipei Main Hospital) beds in Mackay Memorial Hospital.

During the past decade, Mackay Memorial Hospital conducted 167 clinical trials. In the 10-year time frame, 167 clinical trials started and 42 clinical trials were completed, i.e. on average, 25.1% percent of trials that started reached the finish line to date. In the past 5 years, 77 clinical trials started and 37 clinical trials were completed. i.e. 48.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mackay Memorial Hospital" #1 sponsor was "Mackay Memorial Hospital" with 55 trials, followed by "National Health Research Institutes, Taiwan" with 13 trials sponsored, "Boehringer Ingelheim" with 11 trials sponsored, "Pfizer" with 11 trials sponsored and "Eli Lilly and Company" with 11 trials sponsored. Other sponsors include 136 different institutions and companies that sponsored additional 90 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mackay Memorial Hospital" #1 collaborator was "Mackay Memorial Hospital" with 14 trials as a collaborator, "National Cheng-Kung University Hospital" with 11 trials as a collaborator, "National Taiwan University Hospital" with 11 trials as a collaborator, "Chang Gung Memorial Hospital" with 8 trials as a collaborator and "Taipei Veterans General Hospital, Taiwan" with 8 trials as a collaborator. Other collaborators include 161 different institutions and companies that were collaborators in the rest 121 trials.

According to Clinical.Site data, the most researched conditions in "Mackay Memorial Hospital" are "Atrial Fibrillation" (5 trials), "Hepatocellular Carcinoma" (5 trials), "Breast Cancer" (4 trials), "Breast Neoplasms" (4 trials) and "Carcinoma, Hepatocellular" (4 trials). Many other conditions were trialed in "Mackay Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Mackay Memorial Hospital" are "Drug" (142 trials), "Device" (36 trials), "Other" (23 trials), "Biological" (15 trials) and "Behavioral" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Paclitaxel" (7 trials), "Abemaciclib" (5 trials), "Carboplatin" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Mackay Memorial Hospital" are 205 trials for "All" genders, 30 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 86 active trials in "Mackay Memorial Hospital". 2 are not yet recruiting, 46 are recruiting, 37 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 107 completed trials in Mackay Memorial Hospital, 1 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Mackay Memorial Hospital, 19 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 53 trials that are defined as “Not Applicable".